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abstract
 
The substituted cysteine accessibility approach, combined with chemical modiﬁcation using mem-
brane-impermeant alkylating reagents, was used to identify functionally important structural elements of the rat type
 
IIa Na
 
1
 
/P
 
i
 
 cotransporter protein. Single point mutants with different amino acids replaced by cysteines were made
 
and the constructs expressed in 
 
Xenopus
 
 oocytes were tested for function by electrophysiology. Of the 15 mutants
with substituted cysteines located at or near predicted membrane-spanning domains and associated linker regions, 6
displayed measurable transport function comparable to wild-type (WT) protein. Transport function of oocytes ex-
pressing WT protein was unchanged after exposure to the alkylating reagent 2-aminoethyl methanethiosulfonate
 
hydrobromide (MTSEA, 100 
 
m
 
M), which indicated that native cysteines were inaccessible. However, for one of the
mutants (S460C) that showed kinetic properties comparable with the WT, alkylation led to a complete suppression
of P
 
i
 
 transport. Alkylation in 100 mM Na
 
1
 
 by either cationic {[2-(trimethylammonium)ethyl] methanethiosulfonate
bromide (MTSET), MTSEA} or anionic [sodium(2-sulfonatoethyl)methanethiosulfonate (MTSES)] reagents sup-
pressed the P
 
i
 
 response equally well, whereas exposure to methanethiosulfonate (MTS) reagents in 0 mM Na
 
1
 
 re-
sulted in protection from the MTS effect at depolarized potentials. This indicated that accessibility to site 460 was de-
pendent on the conformational state of the empty carrier. The slippage current remained after alkylation. Moreover,
after alkylation, phosphonoformic acid and saturating P
 
i
 
 suppressed the slippage current equally, which indicated
that P
 
i
 
 binding could occur without cotransport. Pre–steady state relaxations were partially suppressed and their ki-
netics were signiﬁcantly faster after alkylation; nevertheless, the remaining charge movement was Na
 
1
 
 dependent,
consistent with an intact slippage pathway. Based on an alternating access model for type IIa Na
 
1
 
/P
 
i
 
 cotransport,
these results suggest that site 460 is located in a region involved in conformational changes of the empty carrier.
 
key words:
 
mutagenesis • phosphate transport • electrophysiology • 
 
Xenopus
 
 
 
laevis 
 
oocyte
 
INTRODUCTION
 
Type II sodium/phosphate (NaPi-II)
 
1
 
 cotransporters
 
belong to a unique class of Na
 
1
 
-coupled cotransport
proteins that show no amino acid homology to other
known cotransport proteins (Murer and Biber, 1997;
Murer et al., 1998). They can be further subdivided
into two subgroups, type IIa and IIb, based on speciﬁc
motifs in the COOH-terminal region. Type IIa cotrans-
porters are only expressed in the proximal tubule of
the kidney, whereas type IIb are expressed in several tis-
sues, such as lung, small intestine, and testis (Hilﬁker et
al., 1998). Members of these subgroups share an overall
 
amino acid homology of 
 
z
 
57% (Hilﬁker et al., 1998).
Nevertheless, the currently predicted secondary struc-
ture indicates that membrane spanning regions and
some interdomain linking regions have considerably
higher homology (up to 99%; Hilﬁker et al., 1998) be-
tween the two subgroups. This suggests that these re-
gions are responsible for the general functional charac-
teristics that all type II Na
 
1
 
/P
 
i
 
 cotransporters share,
such as high afﬁnity for P
 
i
 
, Na
 
1
 
 dependence, and elec-
trogenicity. Although the transport kinetics of both
subgroups are well characterized (Forster et al., 1997,
1998, 1999a; Hilﬁker et al., 1998), nothing is known
about functionally important sites and domains within
the molecule itself that determine the kinetic charac-
teristics of the type II system, such as voltage depen-
dence, substrate speciﬁcity, and substrate afﬁnity.
One technique that offers considerable potential for
identifying functionally important residues and/or do-
mains is the substituted-cysteine-accessibility method
(SCAM; Akabas et al., 1994) combined with the appli-
cation of methanethiosulfonate (MTS) derivatives that
react speciﬁcally with cysteine residues (Smith et al.,
 
1975; Kenyon and Bruice, 1977). In particular, charged,
and therefore membrane impermeant, MTS derivatives
have been used extensively to investigate the topology
and structure of membrane-spanning proteins (Akabas
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et al., 1992; Stauffer and Karlin, 1994). For example,
the topology of the serotonin transporter and the K
 
1
 
-
pore Kv2.1 have been studied by substituting several
amino acids with cysteines (Pascual et al., 1995; Chen et
al., 1998). This technique has also enabled identiﬁca-
tion of functionally important regions of the glutamate
carrier EAAT1 (Seal and Amara, 1998) and the so-
dium/glucose cotransporter (SGLT-1; Lo and Silver-
man, 1998a,b). Moreover, the recent ﬁndings by Loo et
al. (1998) that the accessibility of a substituted cysteine
(Q457C) in the putative sugar-translocation domain of
SGLT-1 to MTS reagents is dependent on substrate and
membrane potential, and their ﬁnding of a correlation
between pre–steady state charge movements and ﬂuo-
rescence changes of the labeled cysteine strongly sup-
ports the notion that ligand- and voltage-induced con-
formational transitions are responsible for coupling
Na
 
1
 
 and glucose transport.
In the present study, we have adopted a cysteine re-
placement strategy and substituted 15 selected amino ac-
ids with cysteine residues with the aim of identifying sites
where the reaction with MTS reagents would lead to a
detectable change in transport function. Having no pre-
cedent for the selection of residues, we based our choice
on the following criteria: (a) residues located between
hydrophobic and hydrophilic regions were chosen be-
cause these intervening regions could be likely candi-
dates for substrate binding or conformational changes
during the transport process (Lo and Silverman, 1998a;
Loo et al., 1998) (see Fig. 1), (b) serine or alanine resi-
dues, where present, were selected for cysteine substitu-
tion to minimize changes in the protein, and (c) residues
in the amino or carboxy termini were not mutated be-
cause these are most likely located intracellularly. Fur-
thermore, based on the evolutionary tree of Na
 
1
 
-coupled
P
 
i
 
 cotransporters, both termini are located in quite vari-
able regions (Biber et al., 1996, 1998; Murer and Biber,
1997), which suggested they are not involved in basic
substrate binding or transport processes.
We have used the 
 
Xenopus
 
 oocyte expression system
and electrophysiological methods to characterize the re-
sults of the mutagenesis. We report that of the 15 mu-
tants assayed, only one (S460C) was sensitive to MTS re-
agents. We show that this mutant, under normal condi-
tions, behaved essentially the same as the wild-type (WT)
protein insofar as its kinetic characteristics were con-
cerned. However, after exposure to membrane-imper-
meant MTS reagents, the kinetic properties of the chem-
ically modiﬁed protein suggested that the native Ser-460
lies in a region involved in voltage-dependent conforma-
tional changes during the cotransport process. Moreover,
Ser-460 appeared to be neither involved directly in the
binding of the ﬁrst Na
 
1
 
 ion, nor the subsequent P
 
i
 
 bind-
ing, but alkylation of the substituted cysteine at this site
led to an inhibition of the ﬁnal cotransport transition.
 
MATERIALS AND METHODS
 
Molecular Biology
 
Mutations were introduced following the Quickchange Site-
Directed Mutagenesis Kit manual (Stratagene Inc.). In brief, 10 ng
of the plasmid containing the rat NaPi-IIa cDNA were ampliﬁed
with 2.5 U PfuTurbo
 
®
 
 (Strategene Inc.) DNA polymerase in the
presence of 250 nM of primers. PCR ampliﬁcation was performed
with 20 cycles of 95
 
8
 
C (30 s), 55
 
8
 
C (1min), and 68
 
8
 
C (12 min).
Next, 10 U of Dpn I were added directly to the ampliﬁcation reac-
tion and the sample was incubated for 1 h at 37
 
8
 
C to digest the pa-
rental, methylated DNA. XL1-blue supercompetent cells were
transformed with 1 
 
m
 
l reaction mixture and plated onto LB-ampi-
cillin-methicillin plates. The sequence was veriﬁed by sequencing.
All constructs were cloned in pSport1 (GIBCO BRL). In vitro syn-
thesis and capping of cRNAs were done by incubating the rat NaPi
IIa constructs, previously linearized by NotI digestion, in the pres-
ence of 40 U of T7 RNA polymerase (Promega) and Cap Analogue
(New England Biolabs Inc.) (Werner et al., 1990).
 
Immunoblotting of Oocyte Homogenates
 
Yolk-free homogenates were prepared 3 d after injection (H
 
2
 
O or
cRNA). Pools of ﬁve oocytes were lysed together with 100 
 
m
 
l of
homogenization buffer [1% Elugent (Calbiochem) in 100 mM
NaCl, 20 mM Tris/HCl, pH 7.6], by pipetting the oocytes up and
down (Turk et al., 1996). To pellet the yolk proteins, samples
were centrifuged at 16,000 
 
g
 
 for 3 min at 22
 
8
 
C. 10 
 
m
 
l of the super-
natant in 2
 
3
 
 loading buffer [4% sodium-dodecyl sulfate (SDS), 2
mM EDTA, 20% glycerol, 0.19 M Tris/HCl, pH 6.8, 2 mg/ml bro-
mphenol blue] were separated on an SDS-PAGE gel, and sepa-
rated proteins were transferred to a nitro-cellulose membrane
(Schleicher & Schuell, Inc.). The membrane was then processed
according to standard procedures (Sambrook et al., 1989) using
a rabbit polyclonal antibody raised against an NH
 
2
 
-terminal syn-
thetic peptide of the rat NaPi-IIa cotransporter. The speciﬁcity of
the antibody has been demonstrated previously (Custer et al.,
1994). Immunoreactive proteins were detected with a chemilu-
minescence system (Pierce).
 
Streptavidin Precipitation of Biotinylated Protein
 
Groups of ﬁve oocytes expressing C460S or the WT protein were in-
cubated for 5 min in 100 
 
m
 
M 2-aminoethyl MTS hydrobromide
(MTSEA)–Biotin. Biotin-streptavidin precipitation was performed
as described previously (Hayes et al., 1994): brieﬂy, after taking a
sample for Western blotting, the oocyte homogenate was incubated
for 2 h with streptavidin beads and precipitated proteins were
eluted with 2
 
3
 
 loading buffer at 95
 
o
 
C for 5 min. Samples were
loaded on an SDS-gel and immunoblotted after protein separation.
 
Oocyte Preparation and Injection
 
Stage V–VI oocytes were prepared as previously described (Magag-
nin et al., 1992). Oocytes were incubated in modiﬁed Barth’s solu-
tion (see below). Typically, 10 ng of cRNA in 50 nl of water were in-
jected per oocyte and experiments performed 4–6 d after injection.
 
Solutions and Reagents
 
All standard chemicals and reagents were obtained from either
Sigma Chemical Co. or Fluka AG. The MTS reagents, MTSEA,
[2-(triethylammonium)ethyl] MTS bromide (MTSET), and so-
dium(2-sulfonatoethyl) MTS (MTSES), were obtained form Toronto
Research Biochemicals and freshly prepared in DMSO. The concen-
tration of DMSO did not exceed 1% and control experiments indi-
cated no effect on transport function by DMSO at this concentration.  
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The solution compositions (mM) were as follows. (a) Oocyte in-
cubation (modiﬁed Barth’s solution): 88 NaCl, 1 KCl, 0.41 CaCl
 
2
 
,
0.82 MgSO
 
4
 
, 2.5 NaHCO
 
3
 
, 2 Ca(NO
 
3
 
)
 
2
 
, 7.5 Tris, pH 7.6, and sup-
plemented with antibiotics (10 mg/liter penicillin, streptomycin).
(b) Control superfusate (ND100): 100 NaCl, 2 KCl, 1.8 CaCl
 
2
 
, 1
MgCl
 
2
 
, and 5 HEPES, titrated to pH 7.4 with KOH. For pre–steady
state recording, where necessary, isomolar BaCl
 
2
 
 was substituted
for CaCl
 
2
 
 to reduce contamination from endogenous Ca
 
2
 
1
 
-acti-
vated Cl
 
2 
 
currents that were observed for V
 
 . 2
 
10 mV, except for
experiments involving phosphonoformic acid (PFA), which other-
wise complexes with Ba
 
2
 
1
 
. (c) Control superfusate (ND0): as for
ND100, but with 
 
N
 
-methyl-
 
d
 
-glucamine or choline chloride re-
placing Na
 
1
 
 to maintain iso-osmolar external solutions. Solutions
were titrated with HCl and KOH to pH 7.4. (d) Substrate test solu-
tions: inorganic phosphate (P
 
i
 
) was added to ND100 from a
K
 
2
 
HPO
 
4
 
/KH
 
2
 
PO
 
4
 
 stock preadjusted to pH 7.4. For PFA-contain-
ing solutions, to take account of this being a trisodium salt, the
Na
 
1
 
 concentration of the control solution was increased by 9 mM
to maintain the same transmembrane Na
 
1
 
 gradient.
 
Functional Assays
 
Tracer uptake.
 
The procedure used for the 
 
32
 
P-uptake assay has
been described in detail elsewhere (Werner et al., 1990). 
 
32
 
P-
uptake was measured 3 d after injection of both water- and cRNA-
injected oocytes (
 
n
 
 
 
5 
 
5).
 
Electrophysiology.
 
The standard two-electrode voltage clamp
technique was used as previously described (Forster et al., 1997,
1998). Oocytes were mounted in a small recording chamber (100
 
m
 
l vol) and continuously superfused (5 ml/min) with test solu-
tions precooled to 20
 
8
 
C. Freshly prepared MTS reagents were ap-
plied to the oocyte chamber via the common superfusion mani-
fold or using a 0.5-mm diameter cannula positioned near the cell
and fed by gravity. Unless otherwise indicated, the steady state re-
sponse of an oocyte to P
 
i
 
 was always measured at a holding poten-
tial (V
 
h
 
) 
 
5 2
 
50 mV in the presence of 100 mM Na
 
1
 
. Data were
acquired online using DATAC software and compatible hardware
(Bertrand and Bader, 1986) and sampled at more than twice the
recording bandwidth. Recorded currents were preﬁltered using
an eight-pole low pass Bessel ﬁlter (Frequency Devices, Inc.) that
was set to 20 Hz for the steady state and 500 Hz or 2 kHz for the
pre–steady state measurements. To increase the signal resolution
for pre–steady state measurements, we also employed capacitive
transient subtraction.
 
Kinetic Characterization
 
The modiﬁed Hill equation was ﬁt to the dose-response data:
(1)
where [
 
S
 
] is the substrate concentration, 
 
I
 
pmax
 
 is the extrapolated
maximum current, 
 
K
 
m
 
s
 
 is the concentration of substrate 
 
S
 
, which
gives a half maximum response or apparent afﬁnity constant, and
n
 
 
 
is the Hill coefﬁcient.
Pre–steady state charge movements were quantiﬁed by ﬁrst
subtracting records obtained in 3 mM PFA to eliminate endoge-
nous currents. An exponential ﬁtting routine, based on the Che-
bychev transform (e.g., Axon Instruments, 1998) was used to esti-
mate relaxation time constants. Difference records were inte-
grated to obtain the charge (
 
Q
 
) as a function of transmembrane
voltage (V). 
 
Q
 
–V data were then characterized by ﬁtting a single
Boltzmann function:
(2)
Ip Ipmax S []
n S []
n Km
s () + {}
n
, ¤ =
QQ hyp Qmax 1 ze VV 0.5 – () – kT ¤ [] exp + {} ¤ () , + =
 
where 
 
Q
 
max
 
 is the maximum charge translocated, 
 
Qhyp is the
steady state charge at the hyperpolarizing limit and depends on
the holding potential, V0.5 is the voltage at which the charge is
distributed equally between the two states, z is the apparent va-
lency per cotransporter, e is the electronic charge, k is Boltz-
mann’s constant, and T is the absolute temperature.
RESULTS
Cysteine Mutagenesis and Identiﬁcation of One 
Methanethiosulfonate-sensitive Construct
Fig. 1 shows the location of the residues within the rat
isoform of the Na/Pi-IIa protein that we mutated indi-
vidually to cysteines according to the above criteria. All
mutations were conﬁrmed by DNA sequencing and were
identical to the WT except for the appropriate base
changes. Each of the 15 mutants was expressed in Xeno-
pus oocytes and tested for electrogenic transport activity
under whole cell voltage-clamp conditions. For this ini-
tial functional assay, oocytes were challenged with a
nearly saturating concentration of Pi (1 mM) in the pres-
ence of 100 mM Na1, pH 7.4. The Pi-activated current,
measured at a holding potential of 250 mV, was com-
pared with that of oocytes expressing the WT protein,
obtained from the same donor frog. As shown in Table I,
six mutants were found to be still active and gave compa-
rable electrogenic responses to the wild type.
To test if alkylation of the cysteine residues by the
methanethiosulfonate derivative MTSEA would affect
the basic transport function, as indicated by the above
electrophysiological assay, we incubated oocytes express-
ing these six active mutants, as well as the WT protein, in
100 mM MTSEA, and then retested for activity under the
same conditions as before. The Pi-induced change in
holding current, exhibited by the WT (Fig. 2 A) as well
as ﬁve of the active mutants (S318C, S373C, A393C,
S532C, and S538C; data not shown), was unaffected by
MTSEA (Table I). In contrast, after incubation in
MTSEA, the electrogenic response of mutant S460C
showed a signiﬁcant inhibition (Fig. 2 A) during applica-
tion of 1 mM Pi. Moreover, prolonged incubation (up to
30 min) in the standard bath medium did not lead to a
restoration of function (data not shown). We also found
that after alkylation, 32P uptake of S460C was completely
suppressed (data not shown), which conﬁrmed that Pi
transport was fully inhibited. To demonstrate that the
suppression of electrogenic response was an effect of the
alkylation and not simply due to the addition of charge
in this region (MTSEA is positively charged), we re-
peated the experiment with the negatively charged MTS
reagent, MTSES. Like MTSEA, incubation in 100 mM
MTSES, also induced a positive shift in the baseline cur-
rent during Pi application; i.e., the normal inward cur-
rent induced by Pi was fully suppressed (data not shown).
We also incubated oocytes in 100 mM MTSET, which
has been reported to be less permeant than MTSEA640 Cysteine Mapping of the NaPi-IIa Protein
(Holmgren et al., 1996) and we obtained the same sup-
pression of Pi response (n 5 3). A representative record
is shown in Fig. 2 A. This result suggested that both MT-
SEA and MTSET were acting extracellularly. Moreover,
even at high concentrations (1 mM), all three reagents
(MTSEA, MTSET, MTSES) had no effect on the electro-
genic WT response (data not shown). This was also con-
ﬁrmed in uptake experiments in which there was no sta-
tistical difference in 32P uptake between WT-expressing
oocytes exposed to 1 mM MTSEA, MTSET, or MTSES
and control oocytes. In each case, the 32P uptake was
.20-fold higher than that of water-injected oocytes from
the same donor frog (results not shown). In contrast to
the lack of effect of MTSEA, MTSET, and MTSES on the
WT, we did observe a dose dependency of 32P uptake in
WT-expressing oocytes exposed to the membrane-per-
meant reagent methyl-MTS (Lambert, G., J. Biber, and
H. Murer, manuscript submitted for publication). This
further supported our conclusion that MTSEA, MTSES,
and MTSET were only acting extracellularly. All remain-
ing experiments were performed with MTSEA unless
otherwise indicated.
As a further conﬁrmation that chemical modiﬁcation
(alkylation) of Cys-460 was involved, we incubated oocytes
that had been previously exposed to either MTSEA (n 5
3) or MTSES (n 5 3) in the reducing reagent dithiothre-
itol (DTT, 10 mM, 15 min) and retested for functional
activity. As shown in Fig. 2 B for a representative oocyte
expressing S460C, exposure to 1.5 mM MTSEA sup-
pressed the Pi-induced response to z30% of the initial
magnitude, and subsequent DTT incubation restored
the Pi-activated response almost to the original level.
This ﬁnding was consistent with dealkylation occurring
in Cys-460, which would thereby restore the original Cys
residue and cotransporter function.
The effect of MTSEA on Pi-induced response for
S460C was both time and dose dependent and short
MTSEA exposures (#30 s) resulted in large variations
(up to 50%) in the amount of suppression of the Pi-
activated response for oocytes from the same batch.
Although the speed of recovery from Pi application
Figure 1. Topological repre-
sentation of the rat type IIa so-
dium phosphate cotransporter
(rat NaPi-IIa). Scheme is based
on current hydropathy data and
a recent topology study (Lam-
bert et al., 1999) in which eight
membrane spanning regions
(TM1–TM8) are predicted with
extracellular loops between
TM1–TM2, TM3–TM4, TM5–
TM6, and TM7–TM8, and both
the carboxy and amino termini
are intracellular. (d) Positions of
15 residues that were individually
mutated to cysteines (see meth-
ods and materials).
TABLE I
Electrogenic Activity of Mutant Constructs
cRNA Ip cRNA Ip
nA nA
WT 278.7 6 10.4 A393C 233.3 6 5.8
N140C 0 S418C 0
S166C 0 S434C 0
S190C 0 A460C 241.3 6 7.4
L234C 0 A513C 0
A239C 0 S532C 234.7 6 3.5
S318C 226.4 6 5.2 A538C 241.3 6 5.8
S373C 225.3 6 4.8 S583C 0
Cotransport activity of mutants expressed in Xenopus oocytes, assayed as the
current induced by 1 mM Pi (Ip) in 100 mM Na1, pH 7.4, with the cell
voltage clamped to 250 mV. Ip values are mean 6 SEM (n = 5). Wild-type
response is for oocytes from the same donor frog used to express the
mutant protein. All mutants that showed expression were exposed to 100
mM MTSEA (2 min) and the response to Pi was retested. Only the response
of mutant S460C was suppressed by this procedure.641 Lambert et al.
prevented repeated testing of the Pi response after ex-
posure to MTSEA for times shorter than 1 min, applica-
tion of 100 mM MTSEA, together with continuous
application of Pi, showed that the suppression of Pi-
induced inward current was complete within 2 min
(data not shown). The optimal concentration range was
determined from dose-response data (Fig. 2 C) whereby
the Pi response (1 mM) was tested after successive
2-min applications of increasing concentrations of MT-
SEA. These data gave an apparent half-maximal con-
centration of MTSEA 5 0.5 mM (n 5 5). MTSEA con-
centrations up to 100 mM did not result in a further
change in the Pi response. In all subsequent experi-
ments, therefore, we routinely applied MTSEA at $10
mM for 2–3 min. The response to 1 mM Pi recorded
from oocytes expressing the WT NaPi-IIa under the
same conditions with repeated application of increas-
ing MTSEA concentrations decreased by z20%. This
was within the normally observed rundown limits for
NaPi-IIa when superfused for periods exceeding 30
min (Forster et al., 1999b) and was therefore not attrib-
utable to MTSEA exposure.
Finally, to establish that the loss of transport function
by S460C was due to a speciﬁc reaction of MTSEA with
the Cys-460, we incubated oocytes expressing mutant
S460C, as well as the WT protein, in biotin-labeled
MTSEA (biotin-MTSEA) and precipitated the protein
with immobilized streptavidin (see materials and
methods). Expression of both proteins was conﬁrmed
by Western blot of the lysate before streptavidin precip-
itation. This showed that both were expressed at com-
parable levels (Fig. 3 A). However, as indicated by the
immunoprecipitation shown in Fig. 3 B, only the mu-
tant protein and not the WT could be precipitated after
incubation with the biotin labeled MTSEA.
Mutant S460C Displays Electrogenic Characteristics Typical 
for Type II Na1/Pi Cotransporters
The electrophysiological assay used above provided only a
basic conﬁrmation that mutant S460C behaved like the
WT. Before making a detailed characterization of the ef-
fect of MTS reagents on S460C, we examined whether the
replacement of Ser-460 with a cysteine altered any of the
speciﬁc properties of the cotransporter that have been
previously identiﬁed from steady state and pre–steady
state measurements of the WT (Forster et al., 1998).
We ﬁrst conﬁrmed that S460C exhibited a dose de-
pendency for the respective substrates (Pi, Na1) that
was consistent with the WT. These ﬁndings are shown
in Fig. 4 A for the Pi-activated dose response and B for
the Na1-activated dose response, pooled from repre-
sentative oocytes expressing the mutant S460C. In each
case, a set of original records at the substrate test con-
centrations is given for a representative oocyte. These
were indistinguishable from the typical WT responses
under the same conditions (data not shown). For both
substrate activation data sets, the steady state currents
at the test concentration were normalized to the maxi-
mum current predicted from a ﬁt to the whole data set
Figure 2. Alkylation using MTSEA leads to a suppression of the
electrogenic response in oocytes expressing mutant S460C. (A)
Comparison of the Pi-induced current for an oocyte expressing the
WT NaPi-IIa before and after exposure to 100 mM MTSEA (left)
and two oocytes expressing S460C before and after exposure to
100 mM MTSEA or MTSET for 2 min (right). Bars represent time
of application of 1 mM Pi. Dashed line indicates baseline holding
current level. Note that Pi induces an upward deﬂection in the
holding current after alkylation. (B) Restoration of Pi response by
15-min incubation in 10 mM DTT (right) for a cell expressing
S460C. Incubation in 1.5 mM MTSEA exposure (middle) inhibited
the initial Pi response (left) by 80%. (C) Dependency of the Pi re-
sponse on MTSEA concentration. Inset gives a set of original
records showing Pi response (applied during bar) for an oocyte ex-
pressing S460C after exposure to successive 10-fold increasing
doses of MTSEA from 0.001 to 10 mM. Scale: vertical 50 nA, hori-
zontal 20 s. For this cell, after exposure at 10 mM MTSEA, Pi in-
duced an upward deﬂection of the baseline current. There was no
change in the response after exposure to 100 mM MTSEA. Dose re-
sponse is pooled from ﬁve oocytes. The Pi-induced response was
calculated relative to the Pi-induced current after alkylation in 100
mM MTSEA, and was then normalized to the initial response for
each cell. Curve is a ﬁt of Eq. 1 to the data, which gave an apparent
half-maximal concentration 5 0.5 mM. 642 Cysteine Mapping of the NaPi-IIa Protein
for each cell using the modiﬁed Hill equation (Eq. 1).
The Pi-activated response was determined at 100 mM
Na1 and ﬁts to the data gave a Hill coefﬁcient, nPi 5
1.04 6 0.1 mM and an apparent afﬁnity for Pi (Km
Pi) of
0.08 6 0.01 mM. The Na1 dose response was deter-
mined at 1 mM Pi and ﬁts to the data gave a Hill coefﬁ-
cient, nNa 5 2.4 6 0 2 mM and an apparent Na1 afﬁnity
(Km
Na) of 56 6 4 mM. These parameters were sufﬁ-
ciently close to the previously reported values for the
WT under the same measurement conditions (e.g., nPi 5
0.96, Km
Pi 5 0.057, nNa 5 2.9, Km
Na 5 52 mM; Forster et
al., 1998), as well as control oocytes expressing the WT
tested in the present study (data not shown), for us to
conclude that neither the apparent substrate afﬁnities
nor the inferred stoichiometry was affected by the Cys
mutation. One further steady state property, which
characterizes type IIa Na1/Pi cotransport, namely pH
sensitivity, was also found to be unchanged in the mu-
tant S460C when compared with the WT expressed in
oocytes from the same batch. In 100 mM Na1, a reduc-
tion in superfusate pH from 7.4 to 6.2 gave a 55 6 4%
(n 5 5) suppression of the Pi-induced response (1 mM
total Pi) compared with 58 6 4% (n 5 5) for the WT.
In the absence of Pi and presence of Na1 in the exter-
nal medium, type IIa cotransporters exhibit a Na1-
dependent slippage (or leak) current. For the WT ex-
pressed in oocytes, this is inhibited by the Pi analogue
and competitive inhibitor for Na1/Pi cotransport, PFA
(Forster et al., 1998). As shown in Fig. 4 C (inset) for a
representative oocyte expressing S460C, when chal-
lenged with both 0.3 mM Pi and 3 mM PFA, a signiﬁ-
cant suppression of the Pi-activated response occurred
(trace 2). Moreover, when oocytes were challenged with
PFA alone (trace 3), the holding current at 250 mV was
reduced. Pooled data from oocytes expressing the WT
or S460C from two donor frogs conﬁrmed this behavior
(Fig. 4 C). The data were normalized with respect to
the near saturating Pi response to take account of differ-
ent expression levels. Whereas, the relative inhibition
of the Pi response by PFA was similar for both WT and
S460C, the latter showed a twofold larger PFA-sensitive
current relative to the respective Pi-induced response.
This ﬁnding suggested that the mutation had altered
the kinetics of the cotransporter in the slippage mode.
Voltage dependence was the ﬁnal property of type IIa
Na1/Pi cotransport investigated for the S460C mutant,
normally characterized in terms of steady state and
pre–steady state behavior. Fig. 5 A shows the steady
state voltage dependence of the Pi-induced current
(left current–voltage plot), which was obtained by sub-
tracting the holding current in the absence of Pi from
that under saturating Pi (1 mM) and 100 mM Na1 (pH
7.4). These data indicate that the voltage dependence
of the WT and S460C were indistinguishable for V , 0
mV. Moreover, the voltage dependence of the normal-
ized slippage current (right current–voltage plot) for
Figure 3. Immunodetection of
WT and S460C protein. (A) West-
ern blot obtained from a pool of
ﬁve oocytes injected either with wa-
ter, WT, or S460C cRNA. 10 ml of
the lysates was separated on a 9%
SDS gel and, after blotting, immu-
noreactive proteins were visualized
by incubation with an antibody
against the rat NaPi IIa NH2 termi-
nus. This blot conﬁrms that lysate
from oocytes expressing S460C pre-
sents a similar band (97 kD) to the
WT. (B) Streptavidin precipitation
of oocyte lysate obtained from
pools of ﬁve oocytes injected either
with water, wild type, or S460C
cRNA and incubated with 100 mM
MTSEA-Biotin. Cells were then ho-
mogenized in 100 ml buffer (see
materials and methods) and 90
ml of each lysate was incubated with Streptavidin beads. After wash-
ing, bound proteins were eluted with loading buffer (see materi-
als and methods) and the elute was then treated as for A. Single
band at 97 kD conﬁrms that the alkylated protein was S460C.
Figure 4. Steady state kinetics of
oocytes expressing S460C. (A) Pi
dose response determined from
original records such as shown in
the inset (scale: vertical, 50 nA;
horizontal, 10 s) at 100 mM Na1.
Data points are pooled from four
oocytes from the same batch. Eq. 1
was ﬁt to the dose–response data
for each cell and the data points
were normalized to the predicted
maximum current. Continuous
line is reﬁt of Eq. 1 to the pooled
data, giving a Hill coefﬁcient, nPi 5
1.04 6 0.07 and apparent Pi afﬁn-
ity, Km
Pi 5 0.081 6 0.01 mM. (B)
Na1 dose response determined
from original records such as
shown in the inset (scale: vertical,
50 nA; horizontal, 10 s), at 1 mM
Pi. Data points are pooled from
three oocytes from the same batch.
Data were treated as in A. Fit of Eq. 1 (continuous line) gave a Hill
coefﬁcient nNa 5 2.35 6 0.21 and apparent Na1 afﬁnity Km
Na 5
56.3 6 4.0 mM. (C) Effect of PFA on the slippage mode (left) and
cotransport mode (right) for WT (ﬁlled bars) (n 5 9) and S460C
(open bars) (n 5 5). Inset shows an original recording from a cell
expressing S460C: (1) response to 0.3 mM Pi, (2) response to 0.3
mM Pi and 3 mM PFA, (3) response to 3 mM PFA. Traces have
been aligned to the baseline current in the absence of substrate
(dashed line). For the slippage mode assay, bars represent the ra-
tio of trace 3 response to trace 1 response. For cotransport mode
assay, bars represent the ratio of trace 2 response to trace 1 re-
sponse, both relative to the level in the presence of PFA alone
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the WT and S460C, using 3 mM PFA as the blocking
agent, was essentially unchanged.
Pre–steady state charge movements result from volt-
age-dependent steps in the type II Na1/Pi cotrans-
porter kinetics (Forster et al., 1997, 1998). Fig. 5 B (in-
set) shows typical pre–steady state relaxations recorded
from a representative oocyte expressing S460C. These
relaxations were also blocked by 3 mM PFA, as previ-
ously reported for the WT (Forster et al., 1998). The
voltage dependence of the apparent charge movement
was determined by integrating the current relaxations
that remained after subtraction of the PFA response.
This procedure was used to eliminate any charge move-
ments not speciﬁcally related to S460C that could result
from upregulation of other membrane proteins stimu-
lated by injection of S460C cRNA. As illustrated in Fig.
5 B, the Q–V curve for a representative oocyte express-
ing S460C saturated at extreme potentials for both ON
and OFF charge movements. Boltzmann ﬁts to the
mean of the ON and OFF charge (Eq. 2) gave a mid-
point voltage V0.5 5 254 6 5 mV and apparent valency,
z 5 0.7 6 0.4 (n 5 5). A representative oocyte express-
ing the WT protein under the same measurement con-
ditions gave V0.5 5 250 mV and z 5 0.6. The turnover f
at 250 mV of the cotransporter can be estimated from
Eq. 3:
(3)
where Ip
250 is the Pi-induced current at Vh 5 250 mV.
For S460C, substitution of the Boltzmann ﬁt data gave
f 5 13.5 6 2.3 s21 (n 5 5), compared with f 5 14 s21
for the WT.
These data indicate that neither the voltage depen-
dence of the steady state charge distribution nor the
apparent valency of the cotransporter substantially
changed after mutagenesis. Moreover, the transport
turnover in the cotransport mode was unchanged.
Sensitivity of Mutant S460C to Methanethiosulfonate Reagents
A noteworthy result of incubation in MTSEA on the Pi re-
sponse was the reduction of holding current during Pi
application (Fig. 2 A). We investigated this further by
testing the response to 3 mM Pi or 3 mM PFA before and
after 100 mM MTSEA incubation as shown for a repre-
sentative oocyte in Fig. 6. These substrate concentrations
were chosen to ensure saturation of the responses. After
alkylation, the response to PFA remained unchanged,
whereas the Pi response was now identical to the PFA re-
sponse. Moreover, this behavior was found to be consis-
tent for all potentials in the range 280 to 0 mV (data not
shown). This result suggested that: (a) alkylation of Cys-
460 did not affect the slippage mode, (b) Na1, the cation
responsible for slippage current, was still able to bind to
the carrier after alkylation, and (c) Pi can still bind to the
f Ip
50 – zQ m ¤ , =
carrier after alkylation, but subsequent cotransport was
suppressed. Noninjected oocytes from the same batch
showed small changes in holding current with either Pi
or PFA application, under the same conditions, but
which were ,10% of the responses recorded from
S460C-expressing oocytes.
It has been recently reported for SGLT-1 that mem-
brane voltage and substrates can confer an apparent pro-
tection to cysteine residues from externally applied MTS
reagents (Loo et al., 1998). We therefore investigated
whether similar effects could be observed with mutant
S460C. We found that 10 mM MTSEA applied together
Figure 5. Mutant S460C and wild type show comparable voltage
dependence. (A) Steady state current–voltage curves for represen-
tative cells expressing wild type (h) and S460C (n) for the
cotransport (left) and slippage (right) modes. For cotransport
mode, the current (Ip) represents difference between current in-
duced by 1 mM Pi and current in absence of Pi normalized to the
value at 2100 mV (n 5 4). For slippage mode, the current (Is) rep-
resents difference between the holding current and current in-
duced by 3 mM PFA, normalized to the value at 2100 mV (n 5 4).
SEMs smaller than symbol size are not shown. (B) Pre–steady state
relaxations induced by voltage steps from 260 mV holding poten-
tial to voltages in the range 2140 to 180 mV in ND100 solution.
Inset shows original records before (left) and after (right) applica-
tion of 3 mM PFA. Q–V curve found by integrating the transient
current after subtraction of the PFA response. (j) ON charge
movement, (h) OFF charge movement. Continuous line is ﬁt of
Eq. 2 to mean of ON and OFF charges, which gave ﬁt parameters:
Qmax 5 5.7 nC, z 5 0.7; V0.5 5 251 mV.644 Cysteine Mapping of the NaPi-IIa Protein
with (a) 1 mM Pi, (b) 3 mM PFA, or (c) Na1 replaced by
100 mM N-methyl-d-glucamine offered no protection
since subsequent application of 1 mM Pi resulted in full
suppression of the Pi-activated inward current (data not
shown). In each case, the membrane potential was held
at 250 mV during the entire protocol and MTSEA was
applied only after a steady state holding current had
been reached under the speciﬁc superfusion conditions.
The currently proposed kinetic scheme for type II
Na1/Pi cotransport (see Fig. 9) predicts that a voltage
step will induce pre–steady state relaxations, contrib-
uted by the empty carrier and Na1 binding/debinding,
before reaching the ﬁnal steady state in the slippage
mode. Since this mode appeared to be unchanged by
alkylation, we would still expect pre–steady state charge
movements to be detectable after alkylation. Fig. 7
shows pre–steady state relaxations recorded from a rep-
resentative oocyte for voltage steps to ﬁve test potentials
in the presence (A) and absence (B) of external Na1.
As before, the endogenous capacitive charging tran-
sient was removed by subtracting the response to 3 mM
PFA in ND100. Although MTSEA treatment resulted in
a signiﬁcant apparent suppression of relaxations, there
was still a charge movement detectable after the endog-
enous membrane charging was complete (typically af-
ter 1–1.5 ms). Moreover, the relaxations were signiﬁ-
cantly faster in ND0 solution, which indicated that alky-
lation had altered the kinetics of the empty carrier. The
available signal resolution and low expression levels
(steady state currents induced by 1 mM Pi were typically
100–150 nA) prevented a full analysis of these relax-
ations. Nevertheless, single exponential ﬁtting of relax-
ations induced by large voltage steps indicated that, in 0
mM Na1, alkylation led to an approximately eightfold
faster time constant, as shown in Table II for three test
potentials. Since the relaxations recorded from S460C-
expressing oocytes after MTSEA treatment were compa-
rable with the speed of membrane charging, we also
conﬁrmed that, under the same perfusion conditions,
signiﬁcant charge movements could not be detected
from noninjected oocytes from the same batch once
the main capacitive charging was complete.
In a ﬁnal set of experiments, we investigated whether
holding potential (Vh) during MTSEA application
would also protect against alkylation as reported in the
case of SGLT1 (Loo et al., 1998). As illustrated by the
Figure 6. Effect of alkylation by MTSEA on Pi and PFA response
for cells expressing S460C. Substrate was applied during the pe-
riod indicated by the bar. Cell was voltage clamped to 250 mV.
Note that after alkylation, the 3 mM Pi and 3 mM PFA responses
superimpose and are identical to the PFA response before alkyla-
tion. Vh 5 250 mV.
Figure 7. Pre–steady state charge kinetics are faster after MTSEA
incubation. Recordings of pre–steady state relaxations from a rep-
resentative oocyte expressing S460C, superfused in ND100 solu-
tion (A) and ND0 solution (B) before MTSEA application (100
mM, 2 min, top) and after MTSEA application (middle). Bottom
traces were recorded from a noninjected oocyte from the same
batch under the same superfusion conditions (without MTSEA).
In each case, oocytes were voltage clamped at 260 mV holding po-
tential and records are shown for voltage steps according to the
protocol in A. Each record is the average of eight sweeps with
records obtained in 3 mM PFA, 100 mM Na1 was subtracted to
eliminate capacitive charging transient. Records were low-pass ﬁl-
tered at 2 kHz and sampled at 50 ms/point. All records were
blanked for the ﬁrst 1.5 ms during the charging period of the oo-
cyte. For this cell, the response to 3 mM Pi before MTSEA was
2100 nA, and after MTSEA it was 115 nA relative to the holding
current at 250 mV.645 Lambert et al.
original recordings from representative oocytes ex-
pressing S460C (Fig. 8 A), when MTSEA was applied
during a depolarization to 120 mV in ND100 solution,
the subsequent response to Pi at 250 mV was identical
to that obtained when MTSEA was applied at 250 mV
(Fig. 6). This indicated that in ND100 depolarization to
120 mV did not protect Cys-460. However, when MT-
SEA was applied in ND0 solution, the magnitude of the
Pi response was now dependent on Vh, whereby less in-
hibition was observed at Vh 5 120 mV compared with
the response after alkylation at 250 mV. We repeated
this protocol for individual oocytes voltage clamped to
Vh 5 120, 0, and 220 mV during MTSEA exposure,
and the pooled results (Fig. 8 B) indicate a clear voltage
dependence of inhibition of response by the MTS re-
agent in 0 mM Na1. For each oocyte tested, we con-
ﬁrmed that exposure to MTSEA at Vh 5 250 mV in 100
mM Na1 gave complete inhibition (i.e., the same re-
sponse during PFA exposure; Fig. 6). We were unable to
determine whether at more depolarized Vh further pro-
tection of the MTS action was possible because continu-
ous voltage clamping of oocytes at potentials exceeding
120 mV during the MTSEA application period resulted
in an irreversible and progressive increase in endoge-
nous leak current. This protocol was also repeated with
the anionic MTSES with similar results (data not
shown). This conﬁrmed that accessibility to Cys-460 was
independent of the charge of the alkylating reagent.
DISCUSSION
In this study, we investigated the effect of membrane
impermeant alkylating reagents on mutant constructs
of the type IIa Na1/Pi cotransporter (rat NaPi-IIa).
Amino acid residues, hypothesized to be in functionally
sensitive regions according to speciﬁc criteria based on
the topological scheme for NaPi-IIa (Fig. 1), were re-
placed with cysteine residues. Six of the sites were lo-
cated intracellularly according to this scheme and
TABLE II
The Effect of Alkylation by MTSEA on Pre-Steady State Kinetics
Test condition t (ms) at voltage (mV)
MTSEA Na1 2120 0 160
mM
2 100 5.24 6 0.2 6.8 6 0.9 2.4 6 0.4
1 100 2.48 6 0.4 1.8 6 0.3 1.2 6 0.1
2 0 7.7 6 0.2 7.9 6 0.7 5.4 6 0.7
1 0 1.0 6 0.3 0.9 6 0.2 0.7 6 0.1
Time constants (t) measured by single exponential curve fitting to main
component of the pre–steady state relaxations in response to voltage steps
from a 260-mV holding potential to the indicated voltage. The
endogenous charging component was eliminated by subtracting the
response to PFA (see text). Data is pooled from five oocytes expressing
S460C before (2) and after MTSEA (+) treatment.
Figure 8. Membrane potential protects against MTSEA suppres-
sion of Pi response only in the absence of external Na1. (A) Origi-
nal recordings from two representative oocytes (top and bottom)
from the same donor frog expressing S460C before and after a
2-min exposure to 10 mM MTSEA at different holding potentials.
After alkylation, the response was tested each time with 1 mM Pi at
250 mV in ND100. (Top, 1) Initial response, (2) response after
alkylation at 120 mV holding potential in ND100. (Bottom, 1) Ini-
tial response, (2) response after alkylation at 120 mV in ND0, (3)
response after alkylation at 250 mV in ND0, (4) response after
alkylation at 250 mV in ND100. The dashed line represents the
initial holding current level before Pi application. (B) Pooled data
of the inhibition of the Pi response after alkylation in 0 mM Na1, at
three holding potentials. n 5 3 (220 mV, 0 mV); n 5 5 (120 mV).
For all cells, after reexposure to MTSEA at 250 mV in ND100 solu-
tion, the Pi response was the same as the PFA response. The per-
cent change in the Pi-induced electrogenic response was expressed
as: 100 ? [1 2 (Ip
1 1 Is)/(Ip
2 1 Is)], where Ip
2 and Ip
1 are the Pi-
induced current before and after MTSEA exposure, respectively, Is
is the PFA-induced change in holding current (slippage current),
with all currents expressed as magnitudes. It was assumed that the
slippage was fully suppressed by 3 mM PFA so that the true Pi-
induced response for saturating Pi was given by the change in cur-
rent relative to the holding current during PFA exposure.
might be considered inaccessible to externally applied
MTS reagents. Nevertheless, we included them in this
study since we could neither fully exclude other candi-
date topologies (Paquin et al., 1999), nor exclude the646 Cysteine Mapping of the NaPi-IIa Protein
possibility that conformational changes might render
these sites accessible. In the present study, we have re-
stricted our investigation to the effects of externally ap-
plied MTS reagents since it has been shown that the WT
response is also inhibited when exposed to membrane-
permeant MTS reagents (Lambert et al., 1999). There-
fore, our ﬁnding that external MTSEA did not affect
two functional mutants with cysteines predicted to be
on the trans side (S373C and A393C) does not exclude
the possibility that they are located in functionally im-
portant areas. Further investigations using internally ap-
plied MTS reagents and cysteine deletions would be
necessary to conﬁrm whether or not these residues are
functionally relevant.
Cys-460 Is Alkylated from the cis Side
Of the six functional mutants, only Pi-induced electro-
genic response of construct S460C was suppressed by
MTSEA. Since this was reversible by DTT, and the WT
protein was insensitive to the externally applied MTS
reagents MTSEA, MTSES, and MTSET, these ﬁndings
suggested that only Cys-460 was strongly implicated as
the site of alkylation. Moreover, tracer ﬂux studies con-
ﬁrmed that alkylation had indeed suppressed 32P up-
take. The immunodetection experiments conﬁrmed
that alkylation had left the protein intact and further-
more provided additional evidence that Cys-460 was lo-
cated extracellularly (predicted to be in the third extra-
cellular loop) (Lambert et al., 1999) since S460C, but
not the WT, could be streptavidin-precipitated after in-
cubation with biotin labeled MTSEA. An alternative hy-
pothesis to explain the action of MTS reagents on
S460C could be that mutagenesis has exposed another
cysteine that is accessible for alkylation. Although we
cannot fully exclude this possibility based on our
present data, this would appear unlikely since, with the
exception of augmented slippage current (see below),
the basic kinetic properties of S460C are identical to
the WT. We expect that the conformational changes
that accompany exposure of another cysteine in a func-
tionally sensitive region also result in signiﬁcant
changes in the cotransport kinetics. 
It has been reported that MTSEA is slightly mem-
brane permeant (Holmgren et al., 1996) and this could
lead to difﬁculties in distinguishing between an effect
exclusively related to external cysteines and one also in-
volving internal cysteines. In our hands, we observed no
change in the WT response after incubation in either of
the more charged reagents, MTSET, MTSES, or MT-
SEA, even up to 1 mM concentrations. In contrast, the
membrane-permeant reagent methyl-MTS has been
shown to cause a suppression of the Pi-induced re-
sponse of oocytes expressing the WT protein (our un-
published results). This indicated that alkylation of in-
ternal cysteines can interfere with transport function. In
the present study, the insensitivity of the WT to all three
nominally impermeant reagents, together with the spec-
iﬁcity of their effect on S460C, led us to conclude that
these reagents were only acting from the cis side.
S460C Behaves According to the Ordered, Alternating Access 
Model for Type II Na1/Pi Transport
Based on steady state and pre–steady state kinetics of
the WT rat NaPi-IIa and ﬂounder NaPi-IIb isoforms, we
have proposed a kinetic model for type II Na1/Pi
cotransport (Forster et al., 1997, 1998) depicted in Fig.
9. This model belongs to the alternating access or gated
channel class of cotransporter models (e.g., Läuger,
1991) proposed for other Na1-dependent cotransport
systems, including the sodium–glucose cotransporter
(Kessler and Semenza, 1983; Parent et al., 1992; Loo et
al., 1993,1998). It predicts that accessibility of substrates
to their respective binding sites on the cis and trans
sides of the membrane relies on a reorientation of the
protein, the favored state of which (cis or trans facing)
is determined by substrate availability on the respective
sides and transmembrane potential. Charge move-
ments (measured as pre–steady state relaxations) in-
duced by voltage steps are predicted to arise from the
movement of charges intrinsic to the carrier, as well as
the translocation of charged substrates to their binding
sites within the transmembrane ﬁeld. This scheme con-
trasts with the channel-like substrate hopping model
proposed recently (Su et al., 1996) in which major mo-
lecular conformational changes do not occur and
charge movements arise exclusively from movement of
charged substrates within a channel-like pore, assumed
to contain multiple binding sites. The recent ﬁndings
of Loo et al. (1998) support an alternating access type
model for SGLT-1, whereby conformational changes
are responsible for the coupling of Na1 and sugar trans-
port. Changes in ﬂuorescence of a rhodamine-labeled
cysteine residue and pre–steady state relaxations were
correlated, as well as the accessibility of this cysteine to
MTS reagents and the steady state charge distribution.
In Fig. 9, at least three modes of operation are possi-
ble. In the empty carrier mode, the orientation of the
charged empty carrier is favored towards the cis side
(state 1) when the membrane is depolarized, which in-
creases the accessibility of Na1 ions to a binding site. Af-
ter the binding of one Na1 ion (transition 1 Û 2), the
system operates in the slippage mode, whereby one Na1
ion forms a neutral complex with the empty carrier and
slippage occurs through the protein (transition 2 Û 9)
in the absence of Pi. Occupancy of state 2 increases the
afﬁnity of the protein for Pi, which then binds (transi-
tion 2 Û 3) in its divalent form (Forster et al., 1998), to-
gether with two additional Na1 ions (transitions 3 Û 4
and 4 Û 5). In this cotransport mode (transition 4 Û647 Lambert et al.
5), reorientation of the fully loaded, neutral carrier to
the trans side (transition 4 Û 5) is now favored, and re-
lease of the substrates can occur as a result of the low in-
ternal Na1 concentration. The cycle is completed by a
reorientation of the empty carrier (transition 10 Û 1).
The Pi analogue PFA, which inhibits both slippage
and cotransport modes, is assumed to place the system
in state 2* when bound. This is consistent with the ﬁnd-
ings of Busch et al. (1994), who demonstrated that PFA
acts as a competitive inhibitor for Pi by shifting the ap-
parent Km for Pi without changing the apparent maxi-
mum electrogenic transport rate, Vmax. Since Vmax is de-
termined by the ﬁnal Na1 binding steps (Forster et al.,
1997, 1998). PFA would be expected not to interact di-
rectly with these steps, but rather to compete for occu-
pancy of the Pi binding site. Details of kinetics in the
trans conformation (states 5–10) are as yet unknown;
however, the validity of this model, under zero trans
conditions, has been conﬁrmed by simulations in
which the main features of steady state and pre–steady
state kinetics are adequately predicted (Forster et al.,
1998). Comparison of the kinetics of S460C and the
WT rat NaPi-IIa indicated that the cysteine substitution
did not alter the properties of the cotransport mode.
The apparent afﬁnities for both substrates, pH depen-
dence, and voltage dependence were all similar to the
WT. Moreover, oocytes expressing S460C gave pre–
steady state relaxations both in the presence and ab-
sence of external Na1, as predicted from the kinetic
scheme (Fig. 9). Of signiﬁcance was a 50% increase
slippage current for S460C relative to the Pi response
compared with the WT. Since the turnover in the
cotransport mode appeared to be unaffected by mu-
tagenesis, the increased relative slippage current would
most likely result from increased turnover in the slip-
page mode. Furthermore, since the voltage depen-
dence of the slippage mode was the same for WT and
S460C, this suggested that mutagenesis had altered the
kinetics of transition 2 Û 9 (see Eq. A3, appendix). De-
spite this departure from WT behavior, the general sim-
ilarity of S460C and the WT indicated that the model
scheme (Fig. 9) was also valid for this construct.
Effect of Alkylation on the Kinetics of S460C: 
Structure–Function Implications
Two questions arise with respect to mutant S460C: (a)
Can the behavior of S460C after alkylation be ex-
plained in terms of the above kinetic scheme? and (b)
Which kinetic transitions are associated with the alky-
lated Cys-460?
The change in the steady state characteristics after
alkylation, whereby saturating Pi induced a reduction in
holding current that exactly matched that of PFA both
before and after alkylation, suggested that site 460 was
located in a functionally sensitive region of the mole-
cule. In terms of Fig. 9, an intact slippage pathway after
alkylation indicates that the protein can still cycle
around the loop 1 Û 2 Û 9 Û 10 Û 1, as well as occupy
state 2* when PFA is bound. Moreover, the identical re-
sponses to Pi and PFA after alkylation suggest that state 3
(with Pi bound) is also intact, but alkylation of Cys-460
prevents one or more of the subsequent transitions lead-
ing to the cotransport mode. This behavior would also
strongly suggest that Pi and PFA bind to the same site.
Further support for this interpretation comes from
our ﬁnding that pre–steady state charge movements, al-
beit with signiﬁcantly faster relaxation time constants,
were still detectable after alkylation for both the empty
carrier and slippage modes. From our recordings, it ap-
peared that alkylation also caused a suppression of the
charge movement, even though the magnitude of the
slippage current and its steady state voltage dependence
remained unchanged. However, we were unable to re-
solve charge movements at times earlier than 1.5 ms af-
ter the voltage step onset and, therefore, one explana-
tion for this apparent discrepancy between the pre–
steady state and the steady state data might be that part
of the charge movement simply remained undetected.
To investigate this further, we modeled the behavior of
a four-state scheme comprising states 1, 2, 9, and 10 (see
appendix).The model predicts pre–steady state relax-
ations similar to those observed before and after alkyla-
tion. Analysis of the model indicated that the steady state
Figure 9. Kinetic Scheme for Type II Na1/Pi Cotransport. States
occupied in the cis (outward facing) orientation are 1–5. States oc-
cupied in the trans (inward facing) orientation are 6–10. The
three modes of operation that involve transmembrane reorienta-
tion, as revealed by steady state and pre–steady state studies of WT,
are indicated by dark shading: empty carrier (10 Û 1), slippage (2
Û 9), and cotransport (5 Û 6). At least two voltage-dependent
transitions have been identiﬁed: empty carrier (10 Û 1) and ﬁrst
external Na1 binding/release step (1 Û 2). The voltage depen-
dence of the last Na1 binding/release step on the trans side (9 Û
10) has not been characterized. PFA binding places the system in
state 2*, which when occupied prevents the slippage and cotrans-
port modes. The lightly shaded region indicates those transitions
and associated states that have been shown to remain intact after
alkylation. In addition, the zero voltage rate constants for the
empty carrier mode increase after alkylation (see text).648 Cysteine Mapping of the NaPi-IIa Protein
slippage current remains constant, as observed experi-
mentally, if the ratio of the zero voltage rate constants for
the empty carrier (transition 1 Û 10) was held constant
(see Eq. A3, appendix). We simulated effect of alkylation
by arbitrarily increasing both zero voltage rate constants
for this transition 10-fold, to accord with our ﬁnding of
faster pre–steady state relaxations in 0 mM Na1. In terms
of an Eyring–Boltzmann transition rate model, this would
imply that alkylation reduces the height of the apparent
energy barrier of this step. Since the apparent valencies
for the voltage-dependent steps are assumed to remain
the same, the increased rates for the empty carrier confor-
mational change after alkylation would not change the
overall steady state charge distribution.
Our ﬁnding of no difference between anionic and
cationic MTS reagents in suppressing the Pi response
would further suggest that the charge of the alkylated
Cys-460 is not in the electric ﬁeld, and therefore cannot
alter the voltage dependence of the empty carrier. This
is also consistent with an invariant steady state charge
distribution after alkylation. Loo et al. (1998) have re-
ported similar behavior for the Q457C mutant of
SGLT-1, whereby the voltage dependence of accessibil-
ity of the MTS reagents was also found to be indepen-
dent of the valency of the reagent.
That Cys-460 is associated with the conformational
state of the empty carrier is also suggested from our
ﬁnding that in 0 mM Na1 the inhibition of the Pi re-
sponse was dependent on the holding potential during
MTS application; i.e., accessibility to Cys-460 was voltage
dependent. In the empty carrier mode, membrane po-
tential determines the probability of occupancy of state
1 or state 10. Since such a voltage-dependent change of
state implies the movement of charged species within
the membrane, the associated conformational changes
are hypothesized to alter the accessibility of Cys-460. In
100 mM Na1, we found no protection with holding po-
tential (between 250 and 120 mV) and, similarly, no
protection was observed in the presence of either Pi or
PFA (together with 100 mM Na1). These ﬁndings sug-
gest that once the protein is in state 2 (Na1 bound),
state 2* (PFA bound), or state 3 (Pi bound), Cys-460 is
readily accessible by externally applied MTS reagents.
Interestingly, in the study by Loo et al. (1998) of the
SGLT-1 mutant Q457C, alkylation also resulted in inhi-
bition of the cotransport mode, although glucose bind-
ing still occurred, just as our data suggest that Pi can still
bind to S460C. However, in contrast to S460C, the be-
havior of this SGLT-1 mutant after alkylation indicated
that MTS reagents could only access the cysteine resi-
due in the equivalent of state 2 (Na1 bound).
Conclusions
Our ﬁndings indicate that site 460 is located in a func-
tionally sensitive region of the NaPi-IIa molecule, most
likely associated with conformational changes of the
empty carrier. As indicated in Fig. 9, states 10, 1, 2, and
3 remain intact after alkylation. The subsequent transi-
tion or transitions, which are altered by alkylation and
thereby inhibit the cotransport mode, remain to be
identiﬁed. Our ﬁndings complement those of Loo et
al. (1998) for SGLT-1 and provide further support for
the notion that conformational changes accompany
substrate binding in Na1-coupled cotransporters.
APPENDIX
Simulation of a Four-State Scheme to Predict Behavior in 
Slippage Mode
The slippage mode was modeled as the four-state “iso
uni uni” system depicted in Fig. A1 A (Segel, 1975) and
corresponding to states 1, 2, 9, and 10 of the full model
in Fig. 9. Transitions between states were modeled ac-
cording to the Eyring–Boltzmann transition rate theory
(Adrian, 1978). We assumed that the empty carrier has
a valency, zc 5 21, that moves an electrical distance d
through the membrane between the external and in-
ternal Na1 binding sites. A single Na1 ion moves an
equivalent electrical distance a9 on the cis side and a0
on the trans side to the respective binding sites
(Läuger, 1991; Parent et al., 1992) so that a9 1 d 1 a0 5
1. The translocation (step 2 Û 3) with Na1 bound is
electroneutral. The eight pseudo ﬁrst order rate con-
stants, assuming symmetrical energy barriers for each
transition, are then given by:
and m 5 eV/2kT, where, Nao and Nai are the external
and internal Na1 concentrations (M), respectively, V is
the transmembrane voltage, e is the electronic charge, k
is Boltzmann’s constant, T is the absolute temperature,
and k0
12, k0
21, etc., are the rate constants at V 5 0.
Steady State and Pre–Steady State Simulations
The time-dependent, net transmembrane current in re-
sponse to a voltage step is given by the sum of all charge
movements that occur within the transmembrane ﬁeld.
Simulations were performed by solving the differential
k12 Na0k
0
12 a¢m – () exp =
k21 k
0
21 a¢m () exp =
k23 k
0
23 =
k32 k
0
32 =
k34 k
0
34 a² – m () exp =
k43 Naik
0
43 a²m () exp =
k14 k
0
14 dm () exp =
k41 k
0
41 dm – () exp =649 Lambert et al.
equations describing the transitions using the matrix
method to ﬁnd the eigen values and eigen vectors
(Press et al., 1992). Zero voltage rate constants were as-
signed to each transition based on previous simulations
of the WT cotransporter (Forster et al., 1998; see Fig.
A1, legend). The rate constant k32 was deﬁned accord-
ing to the condition for microscopic reversibility so that
k32 5 k0
12 k0
23 k0
34 k0
41/(k0
14 k0
21 k0
43). The rate constant
k0
23 was increased twofold to account for the higher slip-
page observed for S460C. Na1 binding on the trans side
was assumed to be voltage dependent, but at low Nai
this contributes little to the overall voltage dependence.
Fig. A1 B shows simulated pre–steady state ON relax-
ations in response to ideal voltage steps, corresponding
to those obtained in Fig. 7, before (left) and after
(right) alkylation. The effect of alkylation was modeled
by assuming that only the zero-voltage rate constants for
the empty carrier (k0
14, k0
41) were increased 10-fold with
no changes to other parameters to account for the faster
relaxation time constants measured in 0 mM external
Na1 (Table II). Note that for a general four-state system,
three nonzero eigen values exist, which would give three
time constants in the relaxation. The limited signal reso-
lution available for our data meant that we could resolve
a single component that corresponds to the slower com-
ponent seen in the simulations. The steady state levels
preceding the voltage step and after the relaxation is
complete are the steady state slippage current at hold-
ing potential and target potential, respectively. For the
parameters chosen, the expanded traces in Fig. A1 C in-
dicate that the slippage current is unaffected by the
change in relaxation kinetics, as our data show. Note
that the effect of ﬁnite voltage-clamp speed and signal
ﬁltering on the relaxation time course have not been in-
cluded in the simulations. Moreover, blanking the ﬁrst
1.5 ms of the recordings (Fig. 7) would signiﬁcantly re-
duce the amount of detectable charge after alkylation.
A Steady State Approximation
Here we consider the dependence of the steady state
current on the rate constants under rate-limiting condi-
tions. The only transmembrane transition involving net
charge transfer is 1 Û 4, therefore the steady state cur-
rent, Is, is given by Eq. A1:
(A1)
where C1 and C4 are the relative occupancies of states 1
and 4, respectively, and F is the Faraday constant. C1
and C4 can be found using the King-Altman method
(Segel, 1975) and, setting zc 5 21:
(A2)
If transition 2 Û 3 is rate limiting, Eq. A2 further sim-
pliﬁes to:
(A3)
Eq. A3 shows that for ﬁxed Na1 concentrations and ap-
parent valencies, Is is a function of k0
23 and the ratios of
zero voltage rate constants for the other transitions.
Is z – cFC 1k14 C4k41 – () , =
Is Fk 14k43k32k21 k41k12k23k34 – ()
k23 k41k34 k41k12 k14k34 k14k43 k12k34 k12k43 +++++ ()
k32 k41k21 k41k12 k14k43 k43k21 k12k43 ++++ ()
k41k34 k12 k21 + () k14k21 k34 k43 + ()
+
++
[
]
¤
.
=
Is Fk
0
23 Nai m () exp Nao m – () exp – []
k
0
21 k
0
12 ¤ ( ) a¢ a² – d – () m [] exp
1 k
0
14 k
0
41 ¤ + () 2dm () exp []
Nao m – () exp k
0
14 k
0
41 ¤ ()
k
0
21 k
0
12 ¤ () k
0
43 k
0
34 ¤ () Nai m () exp
++
{
}
¤
.
»
Figure A1. Simulations of slippage mode behavior. (A) Four
state kinetic scheme used to simulate the slippage mode. (B) Sim-
ulated currents in response to voltage steps indicated in the inset.
The parameters for the simulations on the left were: k0
12 5 8, 000
M21 s21, k0
21 5 2,000 s21, k0
23 5 5 s21, k0
14 5 120 s21, k0
41 5 60 s21,
k0
34 5 100 s21, k0
43 5 1,000 M21 s21, a9 5 0.3, a0 5 0.3, d 5 0.4,
Nao 5 0.1 M, Nai 5 0.01 M, T 5 208C. The effect of alkylation
(right) was simulated by a 10-fold increase in k0
14 and k0
41. (C) Ex-
panded view of the traces in A, which also shows the steady state
current levels under the two conditions. The broken line indicates
zero baseline current. Note that the current scale (eu, electronic
units) gives the apparent charge movement per cotransporter.650 Cysteine Mapping of the NaPi-IIa Protein
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